Prospectus: information for the user
Novidol 50 mg/g gel
Ibuprofen
Read the entire prospectus carefully before starting to use this medication because it contains important information for you.
Follow the administration instructions of the medication contained in this prospectus or as indicated by your doctor, pharmacist, or nurse exactly.
Contents of the prospectus:
Novidol is presented in the form of a gel for cutaneous use. This medication belongs to the group of topical anti-inflammatory drugs.
This medication is indicated in adults and adolescents from 12 years of age for the local relief of pain and mild and occasional inflammation caused by: minor bruises, blows, sprains, torticollis, or other contractures, back pain (lumbalgias), or mild sprains caused as a consequence of a twist.
Do not use Novidol
Warnings and precautions
Consult your doctor or pharmacist before starting to use Novidol.
Be especially careful with Novidol:
Severe skin reactions, such as exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), acute generalized exanthematous pustulosis (AGEP), have been reported in association with ibuprofen treatment. Interrupt treatment with Novidol and seek immediate medical attention if you notice any of the symptoms related to these severe skin reactions described in section 4.
Other medications and Novidol
Inform your doctor or pharmacist that you are using, have recently used, or may need to use any other medication.
Do not apply other cutaneous preparations to the same area of skin where you are using this medication.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, consult your doctor or pharmacist before taking this medication.
Do not use Novidol if you are in the last 3 months of pregnancy. You should not use Novidol during the first 6 months of pregnancy unless it is clearly necessary and your doctor advises you to do so. If you need treatment during this period, you should use the lowest dose for the shortest possible time.
Oral forms (e.g., tablets) of ibuprofen may cause adverse reactions in the fetus. It is unknown if the same risk applies to Novidol when used on the skin.
Driving and using machines
No effects on the ability to drive vehicles and use machinery have been described when used externally on the skin.
Novidol contains benzyl alcohol and wild herb essence
This medication contains 10 mg of benzyl alcohol in each gram of gel. Benzyl alcohol may cause allergic reactions. Benzyl alcohol may cause moderate local irritation.
This medication contains wild herb essence with 3-Methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one, Amyl cinnamaldehyde, Amyl cinnamaldehyde alcohol, Anisic alcohol, Benzyl alcohol, Benzyl benzoate, Benzyl cinnamate, Benzyl salicylate, Cinnamaldehyde, Cinnamic alcohol, Citral, Citronellol, Coumarin, d-Limonene, Eugenol, Farnesol, Geraniol, Hexyl cinnamaldehyde, Hydroxycitronellal, Hydroxy methyl pentyl cyclohexene carboxaldehyde, Isoeugenol, Lilial, Linalool, Methyl heptin carbonate, Oakmoss extract, and Treemoss extract, which may cause allergic reactions.
Follow the administration instructions of this medication contained in this prospectus or as indicated by your doctor or pharmacist exactly. In case of doubt, ask your doctor or pharmacist.
The recommended dose in adults and adolescents from 12 years of age is 3 to 4 applications per day.
This medication is for external cutaneous use only, exclusively on intact skin. Apply a thin layer of the gel to the painful area through gentle massage to facilitate penetration.
Wash your hands after each application.
If you use more Novidol than you should
Due to its external use, it is unlikely that cases of intoxication will occur. In case of accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
Like all medications, this medication can cause side effects, although not everyone will experience them.
Uncommon (may affect up to 1 in 100 people): in the application area, redness, skin inflammation (dermatitis), local irritation, and itching may occur, which disappear when treatment is discontinued.
Rare (may affect up to 1 in 1,000 people): sun-induced dermatitis (skin inflammation).
Frequency not known (cannot be estimated from available data): the skin becomes sensitive to light.
Interrupt treatment with ibuprofen and seek immediate medical attention if you notice any of the following symptoms:
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a side effect that does not appear in this prospectus. You can also report them directly through the Spanish Medication Surveillance System for human use: www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
No special storage conditions are required.
Do not use this medication after the expiration date that appears on the packaging after "CAD". The expiration date is the last day of the month indicated.
Medications should not be thrown away through the sewers or in the trash. Deposit the packaging and medications you no longer need at the SIGRE point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.
Composition of Novidol
The active ingredient is ibuprofen. Each gram of gel contains 50 mg of ibuprofen.
The other components (excipients) are: sodium hydroxide, isopropyl alcohol, hydroxyethyl cellulose, benzyl alcohol, wild herb essence, and purified water.
Appearance of the product and package contents
Transparent, colorless, or slightly yellowish gel. It is presented in a closed aluminum tube with a white polyethylene screw cap containing 60 grams or 100 grams of gel.
Marketing authorization holder and manufacturer
Marketing authorization holder
MENARINI CONSUMER HEALTHCARE, S.A.U.
Guifré, 724 E-08918 Badalona (Barcelona) Spain
Manufacturer
Industria Química y Farmacéutica VIR S.A
C/ Laguna 66-70, Polígono Industrial Urtinsa II,
28923 Alcorcón (Madrid)
Spain
Date of the last revision of this prospectus: January 2024.
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for NOVIDOL 50 mg/g GEL – subject to medical assessment and local rules.